Fr‑HMGB1 and ds‑HMGB1 activate the kynurenine pathway via different mechanisms in association with depressive‑like behavior

Wang,Bo; Lian,Yong‑Jie; Su,Wen‑Jun; Liu,Lin‑Lin; Li,Jia‑Mei; Jiang,Chun‑Lei; Wang,Yun‑Xia

doi:10.3892/mmr.2019.10225

Fr‑HMGB1 and ds‑HMGB1 activate the kynurenine pathway via different mechanisms in association with depressive‑like behavior

Authors:
- Bo Wang
- Yong‑Jie Lian
- Wen‑Jun Su
- Lin‑Lin Liu
- Jia‑Mei Li
- Chun‑Lei Jiang
- Yun‑Xia Wang
View Affiliations

Affiliations: Laboratory of Stress Medicine, Department of Psychology and Mental Health, Second Military Medical University, Shanghai 200433, P.R. China
Published online on: May 9, 2019 https://doi.org/10.3892/mmr.2019.10225
Pages: 359-367
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Our previous study reported that fully reduced high mobility group box 1 (fr‑HMGB1) and disulfide HMGB1 (ds‑HMGB1) induce depressive‑like behavior; however, the underlying mechanisms remain unclear. In the present study, the induction of depression via the kynurenine pathway by different redox states of HMGB1 was investigated in vivo and in vitro. To evaluate the expression of enzymes of the kynurenine pathway, reverse transcription‑quantitative PCR and western blot analyses were conducted. Additionally, cytokine levels were measured by ELISAs. Following intracerebroventricular injection of ds‑ and fr‑HMGB1, behavioral tests were performed, revealing the presentation of depressive‑like behavior, and essential proteins in the kynurenine pathway were demonstrated to be upregulated at the mRNA level, suggesting that ds‑ and fr‑HMGB1 contributed to the development of this behavior via the kynurenine pathway. ds‑HMGB1 directly activated the kynurenine pathway and cytokines such as tumor necrosis factor‑α (TNF‑α) and interleukin‑1β (IL‑1β) in the hippocampal tissue. Conversely, fr‑HMGB1 upregulated the aforementioned factors only following treatment with H2O2. These findings indicated that ds‑HMGB1 induced depression in a manner associated with the kynurenine pathway, whereas oxidation of fr‑HMGB1 evoked activation of the kynurenine pathway, resulting in depressive behavior.

View Figures

View References

1	Magna M and Pisetsky DS: The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol Med. 20:138–146. 2014. View Article : Google Scholar : PubMed/NCBI
2	Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, Fan XG, Yan Z, et al: HMGB1 in health and disease. Mol Aspects Med. 40:1–116. 2014. View Article : Google Scholar : PubMed/NCBI
3	Avgousti DC, Herrmann C, Kulej K, Pancholi NJ, Sekulic N, Petrescu J, Molden RC, Blumenthal D, Paris AJ, Reyes ED, et al: A core viral protein binds host nucleosomes to sequester immune danger signals. Nature. 535:173–177. 2016. View Article : Google Scholar : PubMed/NCBI
4	Lian YJ, Gong H, Wu TY, Su WJ, Zhang Y, Yang YY, Peng W, Zhang T, Zhou JR, Jiang CL and Wang YX: Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1. Brain Behav Immun. 59:322–332. 2017. View Article : Google Scholar : PubMed/NCBI
5	Balosso S, Liu J, Bianchi ME and Vezzani A: Disulfide-containing high mobility group box-1 promotes N-methyl-D-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons. Antioxid Redox Signal. 21:1726–1740. 2014. View Article : Google Scholar : PubMed/NCBI
6	Mazarati A, Maroso M, Iori V, Vezzani A and Carli M: High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and receptor for advanced glycation end products. Exp Neurol. 232:143–148. 2011. View Article : Google Scholar : PubMed/NCBI
7	Frank MG, Weber MD, Watkins LR and Maier SF: Stress sounds the alarmin: The role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming. Brain Behav Immun. 48:1–7. 2015. View Article : Google Scholar : PubMed/NCBI
8	Yang H, Antoine DJ, Andersson U and Tracey KJ: The many faces of HMGB1: Molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol. 93:865–873. 2013. View Article : Google Scholar : PubMed/NCBI
9	Frank MG, Weber MD, Fonken LK, Hershman SA, Watkins LR and Maier SF: The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: A role for the NLRP3 inflammasome. Brain Behav Immun. 55:215–224. 2016. View Article : Google Scholar : PubMed/NCBI
10	Coppen AJ: Depressed states and indolealkylamines. Adv Pharmacol. 6:283–291. 1968. View Article : Google Scholar : PubMed/NCBI
11	Carlsson A, Corrodi H, Fuxe K and Hökfelt T: Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. Eur J Pharmacol. 5:357–366. 1969. View Article : Google Scholar : PubMed/NCBI
12	Schildkraut JJ: The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry. 122:509–522. 1965. View Article : Google Scholar : PubMed/NCBI
13	Lapin IP and Oxenkrug GF: Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet. 1:132–136. 1969. View Article : Google Scholar : PubMed/NCBI
14	Maddison DC and Giorgini F: The kynurenine pathway and neurodegenerative disease. Semin Cell Dev Biol. 40:134–141. 2015. View Article : Google Scholar : PubMed/NCBI
15	Dantzer R, O'Connor JC, Lawson MA and Kelley KW: Inflammation-associated depression: From serotonin to kynurenine. Psychoneuroendocrinology. 36:426–436. 2011. View Article : Google Scholar : PubMed/NCBI
16	Brooks AK, Lawson MA, Smith RA, Janda TM, Kelley KW and McCusker RH: Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus. J Neuroinflammation. 13:982016. View Article : Google Scholar : PubMed/NCBI
17	Wang B, Lian YJ, Su WJ, Peng W, Dong X, Liu LL, Gong H, Zhang T, Jiang CL and Wang YX: HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway. Brain Behav Immun. 72:51–60. 2018. View Article : Google Scholar : PubMed/NCBI
18	Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, De Marchis F, Liu J, Antonelli A, Preti A, Raeli L, et al: Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med. 209:1519–1528. 2012. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Cryan JF, Mombereau C and Vassout A: The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev. 29:571–625. 2005. View Article : Google Scholar : PubMed/NCBI
21	Liu MY, Yin CY, Zhu LJ, Zhu XH, Xu C, Luo CX, Chen H, Zhu DY and Zhou Q: Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc. 13:1686–1698. 2018. View Article : Google Scholar : PubMed/NCBI
22	Seibenhener ML and Wooten MC: Use of the open field maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp. e524342015.PubMed/NCBI
23	Liu YN, Peng YL, Liu L, Wu TY, Zhang Y, Lian YJ, Yang YY, Kelley KW, Jiang CL and Wang YX: TNFα mediates stress-induced depression by upregulating indoleamine 2,3-dioxygenase in a mouse model of unpredictable chronic mild stress. Eur Cytokine Netw. 26:15–25. 2015.PubMed/NCBI
24	Zhang Y, Liu L, Liu YZ, Shen XL, Wu TY, Zhang T, Wang W, Wang YX and Jiang CL: NLRP3 inflammasome mediates chronic mild stress-induced depression in mice via neuroinflammation. Int J Neuropsychopharmacol. 18(pii): pyv0062015. View Article : Google Scholar : PubMed/NCBI
25	Yang H, Lundbäck P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, Al-Abed Y, Andersson U, Tracey KJ and Antoine DJ: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med. 18:250–259. 2012. View Article : Google Scholar : PubMed/NCBI
26	Tang D, Kang R, Zeh HJ III and Lotze MT: High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal. 14:1315–1335. 2011. View Article : Google Scholar : PubMed/NCBI
27	Guillemin GJ, Smith DG, Smythe GA, Armati PJ and Brew BJ: Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv Exp Med Biol. 527:105–112. 2003. View Article : Google Scholar : PubMed/NCBI
28	Schwarcz R and Pellicciari R: Manipulation of brain kynurenines: Glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther. 303:1–10. 2002. View Article : Google Scholar : PubMed/NCBI
29	Du F, Schmidt W, Okuno E, Kido R, Köhler C and Schwarcz R: Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus. J Comp Neurol. 321:477–487. 1992. View Article : Google Scholar : PubMed/NCBI
30	Piani D, Spranger M, Frei K, Schaffner A and Fontana A: Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol. 22:2429–2436. 1992. View Article : Google Scholar : PubMed/NCBI
31	Goldstein RS, Gallowitsch-Puerta M, Yang L, Rosas-Ballina M, Huston JM, Czura CJ, Lee DC, Ward MF, Bruchfeld AN, Wang H, et al: Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock. 25:571–574. 2006. View Article : Google Scholar : PubMed/NCBI
32	Kokkola R, Li J, Sundberg E, Aveberger AC, Palmblad K, Yang H, Tracey KJ, Andersson U and Harris HE: Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum. 48:2052–2058. 2003. View Article : Google Scholar : PubMed/NCBI
33	Zhao H, Liu Z, Shen H, Jin S and Zhang S: Glycyrrhizic acid pretreatment prevents sepsis-induced acute kidney injury via suppressing inflammation, apoptosis and oxidative stress. Eur J Pharmacol. 781:92–99. 2016. View Article : Google Scholar : PubMed/NCBI
34	Lee G, Espirito Santo AI, Zwingenberger S, Cai L, Vogl T, Feldmann M, Horwood NJ, Chan JK and Nanchahal J: Fully reduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to G_Alert-. Proc Natl Acad Sci USA. 115:E4463–E4472. 2018. View Article : Google Scholar : PubMed/NCBI